EN
HI
Summary
As of 13 Nov, 2026, Alembic Pharmaceuticals stock price is ₹1047.25. During the trading session, the stock has moved between an intraday low of ₹1030.15 and an intraday high of ₹1055.00. Over the last 52 weeks, Alembic Pharmaceuticals has traded between ₹635.80 and ₹1055.70.
The stock has recorded a trading volume of 4,52,715 shares,. Its Average Traded Price (ATP) is ₹1045.11, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹1047.25.
Alembic Pharmaceuticals has an upper circuit limit of ₹1235.90 and a lower circuit limit of ₹824.00. The total value traded stands at ₹47.31 CR, and the delivery percentage for the day is 57.56%.
The stock is currently traded with a market lot size of 1. Alembic Pharmaceuticals also offers a dividend yield of 1.17%.
Alembic Pharmaceuticals Share Price Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
4.53 L
Market Cap
20585.07 CR
LTQ@LTP
10@1047.25
ATP
1045.11
Var Margin
16.85 %
Circuit Range
824-1235.9
Delivery %
57.56 %
Value
47.31 CR
ASM/GSM
No
Market Lot
1
Alembic Pharmaceuticals Fundamentals
P/E Ratio
23.98
P/B Ratio
3.4
Div. Yield
1.17
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Alembic Pharmaceuticals Resistance and Support
Pivot 1034.2
Resistance
First Resistance
1047.25
Second Resistance
1064.55
Third Resistance
1077.6
Support
First Support
1016.9
Second Support
1003.85
Third Support
986.55
Alembic Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 1037 | 1047.25 | 1.68% | 1055 | 1030.15 |
| Wed Nov 11 2026 | 1023 | 1029.94 | 1.24% | 1051.5 | 1021.15 |
| Mon Nov 09 2026 | 1015.09 | 1017.29 | 0.72% | 1055.69 | 1006.29 |
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-04 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals received USFDA final approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). The product has an estimated US market size of US$20 million and was developed jointly with Orbicular Pharmaceutical Technologies.
Nov 04 2026 21:56:48
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals announced an expanded collaboration with DifGen Pharmaceuticals for the US market. The partnership targets a portfolio of over 20 complex generics with an aggregate reference market of approximately US$5 billion. Initial launches are expected from FY28.
Nov 04 2026 14:40:37
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Acutaas Chemicals Ltd.
3996.10
79.20 (2.02%)
Krishna Institute of Medical Sciences Ltd
727.30
1.15 (0.16%)
Rubicon Research Ltd.
1717.30
-6.00 (0.35%)
Neuland Laboratories Ltd.
20923.00
719.00 (3.56%)
Granules India Ltd.
840.50
41.25 (5.16%)
Caplin Point Laboratories Ltd.
2386.30
-134.00 (5.32%)
Astrazeneca Pharma India Ltd.
6438.50
-68.50 (1.05%)
Onesource Specialty Pharma Ltd.
1620.00
38.30 (2.42%)
Shilpa Medicare Ltd.
989.65
55.50 (5.94%)
Pfizer Ltd.
3864.40
-28.90 (0.74%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 1047.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 23.98. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 3.4. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 20585.07 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1055.70 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in APLLTD
